[Delta-sleep peptide as a modulator of cardiac activity: theoretical recommendations for practice].
Ul'ianinskiĭ. L S LS; Ivanov. V T VT; Mikhaleva. I I II; Sudakov. K V KV
Key Findings
- DSPP at 60 nm/kg lengthened vagal effects and reduced sympathetic influence on the heart in rabbits and rats.
- The peptide blocked stress‑induced blood‑pressure spikes caused by hypothalamic stimulation, improving survival under acute emotional stress.
- DSPP stabilized heart electrical activity and reduced ventricular ectopic beats, showing anti‑arrhythmic properties in animal models.
Practical Outcomes
- For now, the findings are limited to animal research, so there’s no direct protocol you can apply. The data suggest that, if future human trials confirm safety and efficacy, DSPP might become a tool for managing stress‑related heart rhythm issues. Until such trials are done, it remains a theoretical candidate rather than an actionable supplement.
Summary
In animal studies, a peptide called delta‑sleep peptide (DSPP) was shown to calm the heart by boosting vagal activity and dampening sympathetic signals. It helped keep the heart's rhythm stable during stressful situations and reduced dangerous heart‑beat spikes. The researchers suggest it could someday be tested in people to prevent stress‑related arrhythmias, but no human data exist yet.
Abstract
In acute and chronic animal (rabbits, rats) experiments it has been shown that delta-sleep producing peptide (DSPP) exerts a noticeable effect on the cardiac function and regulation. DSPP at a dose of 60 nm/kg can prolong the effects of vagus and inhibit those of sympathetic nerves on the cardiac function and, consequently, can influence the function of choline- and adrenergic transmitters. DSPP blocks pressor vascular reactions in response to direct electrical stimulation of ventromedian hypothalamus and thus increases the survival of animals exposed to an acute emotional stress. DSPP normalizes the electrical stability of the heart and produces an antiarrhythmic effect on ventricular ectopic beats that occur in response to emotional stresses. In view of this, DSPP can be recommended for clinical trials as a drug preventing cardiac arrhythmias in stressful situations.
Study Information
pubmed
1990